Mobile Site ›
Print Friendly View

Test ID: EGFR    
EGFR Gene, Mutation Analysis, Common Mutation Panel, Tumor

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Identifying non-small cell lung cancers that may respond to epidermal growth factor receptor-tyrosine kinase inhibitor therapies

Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)

Test IDReporting NameAvailable SeparatelyAlways Performed
SLRVWSlide ReviewNoYes

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

When this test is ordered, slide review will always be performed at an additional charge.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) Analysis

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

EGFR Gene, Mutation Analysis, Tumor

Aliases Lists additional common names for a test, as an aid in searching

EGFR
Epidermal growth factor receptor
Gefitinib
Erlotinib
EGFR-TKI
EGFR-tyrosine kinase inhibitor
Non-small cell lung cancer
NSCLC